Andriette Arp-Dessau
Esbjerg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B-cell lymphoma, a Danish population-based analysis.
Journal: British journal of haematology
Published: February 03, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting.
Journal: European journal of haematology
Published: September 29, 2024
The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study.
Journal: Leukemia & lymphoma
Published: September 03, 2024
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Journal: British journal of haematology
Published: June 24, 2023
Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study.
Journal: Journal of geriatric oncology
Published: June 23, 2023
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study.
Journal: Clinical epidemiology
Published: December 02, 2022
Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators.
Journal: American journal of hematology
Published: November 02, 2021
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 25, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026